Dopamine, by acting through its D2 receptor, inhibits insulin-like growth factor-I (IGF-I)-induced gastric cancer cell proliferation via up-regulation of Krüppel-like factor 4 through down-regulation of IGF-IR and AKT phosphorylation
about
Immunomodulatory Effects Mediated by DopamineDopamine regulates mobilization of mesenchymal stem cells during wound angiogenesis.Promotion of initial anti-tumor effect via polydopamine modified doxorubicin-loaded electrospun fibrous membranes.Akt-signal integration is involved in the differentiation of embryonal carcinoma cellsHigh expression of neuro-oncological ventral antigen 1 correlates with poor prognosis in hepatocellular carcinoma.Dopamine D2 receptors' effects on renal inflammation are mediated by regulation of PP2A function.The potential roles of dopamine in malignant glioma.l-DOPA Decarboxylase (DDC) Expression Status as a Novel Molecular Tumor Marker for Diagnostic and Prognostic Purposes in Laryngeal Cancer.Activation of D2 Dopamine Receptors in CD133+ve Cancer Stem Cells in Non-small Cell Lung Carcinoma Inhibits Proliferation, Clonogenic Ability, and Invasiveness of These Cells.Tumor progression: the neuronal input.Moderate swimming suppressed the growth and metastasis of the transplanted liver cancer in mice model: with reference to nervous system.
P2860
Q28071580-C3A299D9-9FF3-4840-8821-67C19A82D1B9Q34166448-8021FBB5-2FE0-44E3-A659-3EAB1B43DE73Q34371109-0F28AFCF-FD82-46BD-9CE7-6245E4EE0733Q34769493-6D644F89-DA52-4986-9179-E69C32E4F20AQ35114504-95C11BD6-3E67-413B-B7BC-F6C1C196ACDAQ36480352-474749F4-7640-4F3F-A574-3AB031B10755Q38780472-F191A8E7-7A0D-435B-90C0-F5956916E2B9Q39560331-03675F78-51CE-449F-933E-7866942A79EFQ40440133-E7AB99C5-8172-41FF-BCB3-D0CF892452CAQ52318550-8EC9D1D1-1580-4086-837A-73D07E2C67E1Q53209146-6E39A2D1-D402-4891-9CBE-03F5D20758D9
P2860
Dopamine, by acting through its D2 receptor, inhibits insulin-like growth factor-I (IGF-I)-induced gastric cancer cell proliferation via up-regulation of Krüppel-like factor 4 through down-regulation of IGF-IR and AKT phosphorylation
description
2010 nî lūn-bûn
@nan
2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Dopamine, by acting through it ...... IGF-IR and AKT phosphorylation
@ast
Dopamine, by acting through it ...... IGF-IR and AKT phosphorylation
@en
Dopamine, by acting through it ...... IGF-IR and AKT phosphorylation
@nl
type
label
Dopamine, by acting through it ...... IGF-IR and AKT phosphorylation
@ast
Dopamine, by acting through it ...... IGF-IR and AKT phosphorylation
@en
Dopamine, by acting through it ...... IGF-IR and AKT phosphorylation
@nl
prefLabel
Dopamine, by acting through it ...... IGF-IR and AKT phosphorylation
@ast
Dopamine, by acting through it ...... IGF-IR and AKT phosphorylation
@en
Dopamine, by acting through it ...... IGF-IR and AKT phosphorylation
@nl
P2093
P2860
P1476
Dopamine, by acting through it ...... IGF-IR and AKT phosphorylation
@en
P2093
Biswarup Basu
Jahar Majumdar
Partha Sarathi Dasgupta
Saurav Shome
Subhalakshmi Ganguly
Sudipta Roy
Sujit Basu
Tushar Jadhav
P2860
P304
P356
10.2353/AJPATH.2010.100617
P407
P577
2010-11-12T00:00:00Z